|
Sign In to gain access to subscriptions and/or personal tools.
|
Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery
Alexander J.C. Mittnacht*,
Michael Fanshawe,
and
Steven Konstadt
* To whom correspondence should be addressed. E-mail: alexander.mittnacht{at}msnyuhealth.org.
 |
Abstract |
|---|
Valvular heart disease can be an important finding in patients presenting for noncardiac surgery. Valvular heart disease and resulting comorbidity, such as heart failure or atrial fibrillation, significantly increase the risk for perioperative adverse events. Appropriate preoperative assessment, adequate perioperative monitoring, and early intervention, should hemodynamic disturbances occur, may help prevent adverse events and improve patient outcome. This review article aims to guide the practitioner in the various aspects of anesthetic management in the perioperative care of patients with valvular heart disease. The pharmacological approach to optimization of patient outcome with drugs, such as  blockers and lipid-lowering medications (statins), is an evolving field, and recent developments are discussed in this article.
First published on April 7, 2008, doi:10.1177/1089253208316442
Seminars in Cardiothoracic and Vascular Anesthesia 2008;12:33.
A more recent version of this article appeared on March 1, 2008
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
